Vendor, Jersey City, NJ
Scynexis Inc.
UEI H6PSJYEW3DT9, CAGE 33SU8
2 awards and $18,454,788 obligated between January 25, 2024 and September 25, 2026, 100% under full and open competition, against 500.0 offers on average where reported. 9 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $18,454,788 |
| Department of Veterans Affairs | $0 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $18,454,788 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 1 |
Hear when Scynexis Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Scynexis Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Wake Forest University Health SciencesWinston Salem, NC | $66,334,494 |
| University of Pittsburgh - of the Commonwealth System of Higher EducationPittsburgh, PA | $36,515,136 |
| Gigagen Inc.San Carlos, CA | $29,618,613 |
| Synedgen, Inc.Claremont, CA | $21,126,078 |
| University of RochesterRochester, NY | $16,531,151 |
| Flosonics Medical LLCMountain View, CA | $16,326,121 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50126C00007Definitive Contract, September 25, 2026, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advance the Development of SCY-247, a Novel Antifungal Currently in Phase 1 Clinical Trials, for the Treatment of Invasive Candidiasis and PNAICS 541715, PSC AN13 | $18,454,788 |
| 36F79722D0060January 25, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Administrative Change to Update Points of Contact and Signatory Authority FormNAICS 325412, PSC 6505 | $0 |
- Places of performance
- New Jersey
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development6505 Drugs and Biologicals
- Transactions
- 5 across 2 awards